Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US11041000B2 · kind B2 · utility
8Cited by
35References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2020 |
| Grant date | Jun 22, 2021 |
| Priority date | — |
| Expiry date | Aug 24, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/7155
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.